Cargando…
PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S.
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431399/ http://dx.doi.org/10.1097/01.HS9.0000850844.58786.ec |
_version_ | 1784780044867993600 |
---|---|
author | Fonseca, R. Chinaeke, E. Gupta, N. Fu, A. Ran, T. Kaila, S. |
author_facet | Fonseca, R. Chinaeke, E. Gupta, N. Fu, A. Ran, T. Kaila, S. |
author_sort | Fonseca, R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9431399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94313992022-08-31 PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S. Fonseca, R. Chinaeke, E. Gupta, N. Fu, A. Ran, T. Kaila, S. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431399/ http://dx.doi.org/10.1097/01.HS9.0000850844.58786.ec Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Fonseca, R. Chinaeke, E. Gupta, N. Fu, A. Ran, T. Kaila, S. PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S. |
title | PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S. |
title_full | PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S. |
title_fullStr | PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S. |
title_full_unstemmed | PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S. |
title_short | PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S. |
title_sort | pb2003: real-world duration of use and dosing frequency of daratumumab in patients with multiple myeloma in the u.s. |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431399/ http://dx.doi.org/10.1097/01.HS9.0000850844.58786.ec |
work_keys_str_mv | AT fonsecar pb2003realworlddurationofuseanddosingfrequencyofdaratumumabinpatientswithmultiplemyelomaintheus AT chinaekee pb2003realworlddurationofuseanddosingfrequencyofdaratumumabinpatientswithmultiplemyelomaintheus AT guptan pb2003realworlddurationofuseanddosingfrequencyofdaratumumabinpatientswithmultiplemyelomaintheus AT fua pb2003realworlddurationofuseanddosingfrequencyofdaratumumabinpatientswithmultiplemyelomaintheus AT rant pb2003realworlddurationofuseanddosingfrequencyofdaratumumabinpatientswithmultiplemyelomaintheus AT kailas pb2003realworlddurationofuseanddosingfrequencyofdaratumumabinpatientswithmultiplemyelomaintheus |